Pages that link to "Template:Lymphoid and complement immunodeficiency"
From Self-sufficiency
The following pages link to Template:Lymphoid and complement immunodeficiency:
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)- Azathioprine (← links)
- International Classification of Diseases for Oncology (← links)
- List of ICD-9 codes 140-239: neoplasms (← links)
- ICD-10 Chapter II: Neoplasms (← links)
- List of ICD-9 codes 240-279: endocrine, nutritional and metabolic diseases, and immunity disorders (transclusion) (← links)
- ICD-10 Chapter III: Diseases of the blood and blood-forming organs, and certain disorders involving the immune mechanism (transclusion) (← links)
- Template:Immune disorders (redirect page) (← links)
- ATC code L (← links)
- ATC code L03 (← links)
- ATC code L04 (← links)
- Immunostimulant (← links)
- Drug eruption (← links)
- Belatacept (← links)
- Gavilimomab (← links)
- Faralimomab (← links)
- Aselizumab (← links)
- Atorolimumab (← links)
- Belimumab (← links)
- Bertilimumab (← links)
- Cedelizumab (← links)
- Ipilimumab (← links)
- Lerdelimumab (← links)
- Metelimumab (← links)
- Zanolimumab (← links)
- Zolimomab aritox (← links)
- Elsilimomab (← links)
- Inolimomab (← links)
- Odulimomab (← links)
- Vepalimomab (← links)
- Galiximab (← links)
- Gomiliximab (← links)
- Maslimomab (← links)
- Keliximab (← links)
- Lumiliximab (← links)
- Teneliximab (← links)
- Vapaliximab (← links)
- Tremelimumab (← links)
- Erlizumab (← links)
- Fontolizumab (← links)
- Pascolizumab (← links)
- Pexelizumab (← links)
- Reslizumab (← links)
- Rovelizumab (← links)
- Ruplizumab (← links)
- Siplizumab (← links)
- Talizumab (← links)
- Toralizumab (← links)
- Visilizumab (← links)
- Nerelimomab (← links)
- Morolimumab (← links)
